Pivot Archive
All pivots
Medium Biosciences logo

Medium Biosciences

S21
6 people|Active|Website
Machine LearningBiotechAI
47°Significant Pivot
Before

AI-designed Protein Therapeutics

After

AI-designed Affinity Reagents

Full description — before

We develop AI models & new assays to create functional, therapeutic proteins.

Full description — after

Custom affinity reagents, designed for your target and application! We turn advances in AI and protein design into experimentally validated molecular tools, partnering with research teams and diagnostic developers to deliver high-performance affinity reagents in weeks, not months.

Category shift
Biotech & Drug DiscoveryAI Coding Assistants
Summary

Medium Biosciences pivoted from developing therapeutic proteins for drug discovery to creating affinity reagents for research and diagnostics - same AI protein design technology but different market and application.

Detected today · 2026-05-02